Vanderbilt-ingram Cancer Center
Clinical trials sponsored by Vanderbilt-ingram Cancer Center, explained in plain language.
-
New combo therapy targets Hard-to-Treat blood cancers
Disease control CompletedThis early-phase study tested a new drug (TGR-1202) combined with an existing treatment (ruxolitinib) in 60 adults with myelofibrosis or polycythemia vera that stopped responding to standard care. The main goal was to check safety and find the best dose. This is not a cure, but a…
Phase: PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 17, 2026 04:41 UTC
-
Tailored smoking treatment shows promise for vulnerable patients
Disease control CompletedThis study tested a personalized approach to help people quit smoking by matching medication to their nicotine metabolism. 606 adults on Medicaid or Medicare who smoked daily took part. The goal was to see if tailoring treatment improves quit rates.
Phase: PHASE3 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Disease control
Last updated Jun 15, 2026 19:07 UTC
-
Lung nodule biopsy showdown: CT needle vs. High-Tech scope
Diagnosis CompletedThis study compared two ways to biopsy a lung nodule (a small growth): a CT-guided needle through the chest wall, and a navigation bronchoscopy that goes through the windpipe. 288 patients were randomly assigned to one method. The goal was to see which approach gives a clear diag…
Phase: NA • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Diagnosis
Last updated Jun 15, 2026 19:07 UTC
-
Keto diet plus breast cancer drug shows promise in small study
Symptom relief CompletedThis early-phase study tested whether a 2-week very low-carbohydrate (ketogenic) diet combined with the drug letrozole is feasible and tolerable for people with early-stage estrogen receptor-positive (ER+) breast cancer. 31 postmenopausal women participated before surgery. The go…
Phase: EARLY_PHASE1 • Sponsor: Vanderbilt-Ingram Cancer Center • Aim: Symptom relief
Last updated Jun 17, 2026 04:42 UTC